Long-term outcome and toxicity of hypofractionated stereotactic body radiotherapy as a boost treatment for head and neck cancer: The importance of boost volume assessment

Radiation Oncology

Volumn 7, Issue 1, 2012, Pages

  Lee, Dong Soo ^a   Kim, Yeon Sil ^b   Cheon, Jae Seok ^b   Song, Jin Ho ^b   Son, Seok Hyun ^b   Jang, Ji Sun ^b   Kang, Young Nam ^b   Kang, Jing Hyoung ^b   Jung, So Lyoung ^b   Yoo, Ie Ryung ^b   Jang, Hong Seok ^b  

^a Yonsei University College of Medicine   (South Korea)

^b The Catholic University of Korea   (South Korea)

Author keywords

Boost; Head and neck cancer; Hypofractionation; Stereotactic body radiotherapy

Indexed keywords

ADOLESCENT; ADULT; ADVANCED CANCER; AGED; ARTICLE; BONE NECROSIS; BRAIN NECROSIS; CANCER GRADING; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOREDUCTIVE SURGERY; DISEASE SEVERITY; DOSIMETRY; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FOLLOW UP; HEAD AND NECK CANCER; HEAD AND NECK SURGERY; HUMAN; HYPOFRACTIONATED RADIOTHERAPY; MALE; MUCOSAL BLEEDING; MUCOSAL DISEASE; MUCOSAL NECROSIS; MUCOSAL ULCER; OPTIC NERVE DISEASE; ORGANS AT RISK; OUTCOME ASSESSMENT; PREDICTION; RADIATION DOSE DISTRIBUTION; RADIATION DOSE FRACTIONATION; RADIATION INJURY; RETINOPATHY; STEREOTACTIC BODY RADIATION THERAPY; TISSUE NECROSIS; TREATMENT RESPONSE;

EID: 85040656401     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717x-7-85     Document Type: Article

References (18)

1. Chan AT, Teo PM, Ngan RK, et al: Concurrent chemotherapy-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: progression-free survival analysis of a phase III randomized trial. J Clin Oncol 2002, 20:2038-2044
2. Budach W, Hehr T, Budach V, Belka C, Dietz K: A meta-analysis of hyperfractionated and accelerated radiotherapy and combined chemotherapy and radiotherapy regimens in unresected locally advanced squamous cell carcinoma of the head and neck. BMC Cancer 2006, 6:28
3. Brizel DM, Prosnitz RG, Hunter S, et al: Necessity for adjuvant neck dissection in setting of concurrent chemoradiation for advanced headand-neck cancer. Int J Radiat Oncol Biol Phys 2004, 58:1418-1423
4. Bonner JA, Harari PM, Giralt J, et al: Radiotherapy plus cetuximab for squamouscell carcinoma of the head and neck. N Engl JMed 2006, 354:567-578
5. Hong WK, Bromer RH, Amato DA, et al: Patterns of relapse in locally advanced head and neck cancer patients who achieved complete remission after combined modality therapy. Cancer 1985, 56:1242-1245
6. Garofalo MC, Haraf DJ: Reirradiation: a potentially curative approach to locally or regionally recurrent head and neck cancer. Curr Opin Oncol 2002, 14:330-333
7. Marks JE, Bedwinek JM, Lee F, Purdy JA, Perez CA: Dose-response analysis for nasopharyngeal carcinoma: An historical perspective. Cancer 1982, 50:1042-1050
8. Dinshaw KA, Agarwal JP, Ghosh-Laskar S, Gupta T, Shrivastava SK: Radical radiotherapy in head and neck squamous cell carcinoma: an analysis of prognostic and therapeutic factors. Clin Oncol (R Coll Radiol) 2006, 18:383-389
9. Le QT, Tate D, Koong A, et al: Improved local control with stereotactic radiosurgical boost in patients with nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 2003, 56:1046-1054
10. Hara W, Loo BW Jr, Goffinet DR, et al: Excellent local control with stereotactic radiotherapy boost after external beam radiotherapy in patients with nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 2008, 71:393-400
11. Kawaguchi K, Sato K, Horie A, et al: Stereotactic radiosurgery may contribute to overall survival for patients with recurrent head and neck carcinoma. Radiat Oncol 2010, 5:51
12. Yamazaki H, Kodani N, Ogita M, Sato K, Himei K: Reirradiation of head and neck cancer focusing on hypofractionated stereotactic body radiation therapy. Radiat Oncol 2011, 6:98
13. Bentzen SM, Constine LS, Deasy JO, et al: Quantitative Analyses of Normal Tissue Effects in the Clinic (QUANTEC): an introduction to the scientific issues. Int J Radiat Oncol Biol Phys 2010, 76:S3-S9
14. Debus J, Hug EB, Liebsch NJ, et al: Dose volume tolerance of the brainstem after high-dose radiotherapy. Front Radiat Ther Oncol 1999, 33:305-314
15. Jiang GL, Tucker SL, Guttenberger R, et al: Radiation-induced injury to the visual pathway. Radiother Oncol 1994, 30:17-25
16. Kirkpatrick JP, Meyer JJ, Marks LB: The linear-quadratic model is inappropriate to model high dose per fraction effects in radiosurgery. Semin Radiat Oncol 2008, 18:240-243
17. Brenner DJ: The linear-quadratic model is an appropriate methodology for determining isoeffective doses at large doses per fraction. Semin Radiat Oncol 2008, 18:234-239
18. Fletcher GH: Hypofractionation: lessons from complications. Radiother Oncol 1991, 20:10-15